Connect with us

Week ahead – Lockdown easing spurs optimism

Week ahead – Lockdown easing spurs optimism

Published

on

Make or Break

The upcoming week could be a make or break moment for global equities and the demand for safe-haven currencies.

Wall Street bulls seem to have already priced in all the dismal data and are growing confident that US has made it through the worst of new coronavirus cases.  Another positive for the economy is that confidence improved in the functioning of key funding markets, alongside constant bond offering.

The dollar may continue to weaken if coronavirus cases continue to plateau across big cities and on further progress with clinical trials that are showing positive results with the treatment of COVID-19 patients.  With the entire world delivering massive ammounts of QE and fiscal easing, the one trade has been support

Key Economic Releases and Events:

Sunday, April 19th

UK Time Country Relevance Indicator Name Period
23:45 New Zealand High CPI QQ Q1
23:45 New Zealand Medium CPI YY Q1

 

Monday, April 20th

00:50 Japan High Trade Balance Total Yen Mar
09:30 Hong Kong Low Unemployment Rate Mar
14:00 Russia High Unemployment Rate Mar

 

Tuesday, April 21st

07:00 United Kingdom High Claimant Count Unem Chng Mar
07:00 United Kingdom High ILO Unemployment Rate Feb
07:00 United Kingdom Medium Avg Wk Earnings 3M YY Feb
07:00 United Kingdom Medium Avg Earnings (Ex-Bonus) Feb
08:30 Sweden Medium Unemployment Rate Mar
10:00 Germany High ZEW Economic Sentiment Apr
13:00 New Zealand High Milk Auctions 21 Apr, w/e
13:30 Canada High Retail Sales MM Feb
15:00 United States High Existing Home Sales Mar
21:30 United States Not Rated API weekly crude stocks 13 Apr, w/e

 

Wednesday, Apr 22nd

07:00 United Kingdom Low Core CPI MM Mar
07:00 United Kingdom Low Core CPI YY Mar
07:00 United Kingdom Medium CPI MM Mar
07:00 United Kingdom High CPI YY Mar
07:00 Denmark High Consumer Confidence Apr
12:00 Turkey High CBT Weekly Repo Rate Apr
12:00 Turkey High O/N Lending Rate Apr
12:00 Turkey High O/N Borrowing Rate Apr
12:00 Turkey High Late Liquidity Window Rate Apr
13:30 Canada High CPI BoC Core YY Mar
13:30 Canada High CPI BoC Core MM Mar
14:00 Russia High Industrial Output Mar
15:30 United States Not Rated EIA Weekly Crude Stocks 17 Apr, w/e

 

Thursday, Apr 23rd

00:00 Australia High Manufacturing PMI Apr
00:00 Australia High Services PMI Apr
00:00 Australia High Composite PMI Apr
00:00 South Korea Medium GDP Growth QQ Advance Q1
00:00 South Korea Medium GDP Growth YY Advance Q1
01:30 Japan High Jibun Bank Mfg PMI Flash Apr
06:00 Singapore Low Core CPI YY Mar
06:00 Singapore Medium Consumer Price Index YY Mar
08:15 France High Markit Mfg Flash PMI Apr
08:15 France High Markit Serv Flash PMI Apr
08:15 France High Markit Comp Flash PMI Apr
08:30 Germany High Markit Mfg Flash PMI Apr
08:30 Germany High Markit Service Flash PMI Apr
08:30 Germany High Markit Comp Flash PMI Apr
09:00 Euro Zone High Markit Mfg Flash PMI Apr
09:00 Euro Zone High Markit Serv Flash PMI Apr
09:00 Euro Zone High Markit Comp Flash PMI Apr
09:30 United Kingdom High Flash Composite PMI Apr
09:30 United Kingdom High Flash Manufacturing PMI Apr
09:30 United Kingdom High Flash Services PMI Apr
09:30 Hong Kong Not Rated CPI MM NSA Mar
09:30 Hong Kong Not Rated CPI NSA Mar
12:00 Mexico Low Retail Sales YY Feb
12:00 Mexico Low Retail Sales MM Feb
13:30 United States High Initial Jobless Claims 13 Apr, w/e
13:30 United States Low Jobless Claims 4-Wk Avg 13 Apr, w/e
13:30 United States Medium Continued Jobless Claims 6 Apr, w/e
14:00 Russia Low Cbank Wkly Reserves 13 Apr, w/e
14:45 United States High Markit Comp Flash PMI Apr
14:45 United States High Markit Mfg PMI Flash Apr
14:45 United States High Markit Svcs PMI Flash Apr

 

Friday, April 24th

00:30 Japan High CPI, Core Nationwide YY Mar
00:30 Japan High CPI, Overall Nationwide Mar
06:00 Singapore Medium Manufacturing Output MM Mar
06:00 Singapore Medium Manufacturing Output YY Mar
07:00 United Kingdom High Retail Sales MM Mar
07:00 United Kingdom High Retail Sales Ex-Fuel MM Mar
07:00 United Kingdom High Retail Sales YY Mar
07:00 United Kingdom Medium Retail Sales Ex-Fuel YY Mar
09:00 Germany High Ifo Business Climate New Apr
11:30 Russia High Central bank key rate Apr
13:30 United States High Durable Goods Mar
15:00 United States High U Mich Sentiment Final Apr

 

Country 

US

This will be a huge week for the earnings season. Updates from Intel, IBM, SAP, Netflix and Ericsson highlight the first major round of tech results. If US stocks are going to avoid a retest of the March 23rd lows, tech will have to lead the way. Lockheed Martin, Haliburton and Alcoa earnings updates will also be closely watched. 

On the economic data front, the focus falls on the housing, jobless claims and the flash PMI readings. April could be as bad as it gets so Wall Street might be a little forgiving for worse-than-expected misses. 

US Politics 

Capitol Hill will debate how much and when will we see a second round of payments to Americans. Another set direct cash payments to Americans will likely happen but could start to see some resistance if parts of the economy begin to reopen. 

The spread of COVID-19 across America will closely be watched in seven midwestern states. Michigan, Ohio, Wisconsin, Minnesota, Illinois, Indiana and Kentucky are attempting a coordinated effort in reopening the Midwest regional economy. If this goes smoothly, we could see this pretty much solidify some of these battleground states for President Trump. 

UK 

The lockdown has been extended by at least another three weeks, not a surprise given the numbers we’ve been seeing. The number of new cases may be leveling off but the government won’t be taking any risks having been heavily criticized for their initial response. 

Italy 

The return to normality is likely to have many bumps in the road but with each passing week, it’s looking more and more encouraging in Italy. The lockdown has clearly worked which means we’re now into 

easing mode. Shops selling books, stationery and clothes for babies and young children have been allowed to reopen which is a promising first step. 

Spain 

Some businesses in Spain have been allowed to return to work but, as with elsewhere, extreme caution is being urged and the government is likely to take baby steps to begin with. Again though, the trend is extremely encouraging, throughout the region as a whole. 

Eurozone 

The bloc eventually agreed on a €500 billion rescue package for countries hit by the coronavirus, with the ESM making up €240 billion in spending guarantees, the European Investment Bank €200 billion and the rest the European Commission via working schemes. The deal is a typical euro fudge that tries to appeal all parties while satisfying none. In times of stress, the EU has typically delivered the bare minimum needed, late and via the backdoor. Some things never change. 

Turkey 

It’s feared Turkey could become a new hotspot for the coronavirus after the government took much longer to implement lockdown measures, instead prioritizing the economy which had already suffered considerably in recent years. The number of cases have been rising fast since the country started recording them, as has the death toll forcing some to question whether the situation is destined to get much worse. The CBRT announced measures on Friday to mitigate the economic impact and is expected to cut rates next week by 50 basis points, taking the repo rate to 9.25%. 

Russia 

Central bank interest rate decisions have become another entirely unpredictable event in this crisis, with many choosing to not even wait for scheduled meetings to make changes. It’s worth, therefore, taking expectations with a pinch of salt and they will differ depending on the platform you’re looking at. Some are suggesting that the Central Bank of Russia will cut by at least 25 basis points next week but expectations, as ever, are broad. 

South Africa 

The SARB held an unscheduled meeting this week and cut interest rates by 1% to 4.25% as the country heads for a severe contraction this year. The country is now expected to contract by 6.1% vs 0.2% at its last meeting three weeks ago. The country lost its final investment grade credit rating at the end of March. 

China 

On Monday, China expected to cut 1-year Loan Prime Rate by 10 bps to 3.95% and 5-year to 4.65%. No other significant data for the rest of the week. 

China retail sales disappointed suggesting domestic recovery is elusive. Also, markets will look for more data on the possibility that previously recovered cases can spontaneously have COVID-19, in much the same way that malaria reoccurs. 

Hong Kong 

Hong Kong unemployment on Monday is likely to remain officially stable at 3.70%, although the situation on the ground is likely to be at odds with official data. No other significant data. 

Hong Kong remains under tighter restrictions following a recurrence in COVID-19 cases. Progress on this front will be the centre of market attention. 

Singapore 

Inflation and Industrial production Thursday and Friday. After today’s huge rebound in non-oil exports, potential for upside surprise with Industrial Production. Potential positive overflow in SGD, 

Tightened COVID-19 “circuit-breaker” restrictions continue for the 3rd week, most of the economy that can is working from home. Singapore faces a moment of truth in the coming week, with COVID-19 breaking out in worker dormitories. A huge increase in COVID-19 cases has occurred this week from this source.That would be very negative for an economy deep in recession already despite government stimulus efforts. 

India 

No significant data next week. 

Attention remains focused on the number of COVID-19 cases and a timetable for the easing of lockdown restrictions that were recently extended. Social unrest concerns are elevated. The worst is yet to come for India in all likelihood. 

Australia 

RBA minutes Tuesday to be uneventful. No other significant data. 

The AUD has risen 9.0% this month, and the ASX 200 by 11.40% this month. Currency and stock market at the forefront of the peak-virus, reducing lockdown, and central bank reflation trade. That leaves both the currency and the stock market vulnerable unexpected bad news. 

New Zealand 

No significant data with the country entering the last week of the four-week national lockdown. Virus cases appear to have peaked. A lockdown extension could renew pressure on the stock market and currency. 

NZD has rallied 4.1% this month and the stock market by a huge 14.0% on “peak-virus” and a China recovery. Disappointments on either front leave the NZD vulnerable to an aggressive downward reversal.

Japan 

Monday, Japan Balance of Trade. Thursdays Jibun comp. PMI. Friday Inflation Rate. None are expected to materially affect markets. 

Japan’s government has been found wanting in its COVID-19 response and is perceived as putting business and the Olympics first. Cases are increasing along with the scale of lock-downs. 

The Nikkei 225 has rallied 19.0% in the past month on global recovery hopes. Any bad news next week leaves Japan stocks vulnerable to an aggressive sell-off. 

Market 

Oil 

Oil prices are making small gains but continue to trade not far from their lows. The near-term WTI contract is taking a beating though as it approaches expiry, as storage facilities rapidly approach capacity and production isn’t falling fast enough. The inventory data is accelerating higher even as US output declines, now 800,000 barrels a day off its peak a month ago. The prospect of a treatment and economies reopening is obviously positive for prices but the near-term problems aren’t being resolved fast enough. 

Gold 

Gold profit taking has properly kicked in now, with the yellow metal off 2% today and temporarily back below $1,700. The dollar has remained strong despite the bounce in risk appetite, although the prospect of the US economy reopening should be good for the currency. These relationships are never particularly straightforward. Either way, gold is under a little pressure, with $1,680 the key level below now and $1,640 notable below that. 

Bitcoin 

The battle is not over yet, with bitcoin bulls taking another run at the upper end of the $6,500-7,500 range. News of Libra 2.0 overnight may have aided the rebound even if the proposal isn’t quite the digital currency that purists believe in. As we saw before though, that isn’t necessarily important and prices have been boosted just by being in the headlines and this does just that. In this sense, Libra is very much bitcoin’s friend. Whether Libra 2.0 will generate the same level of excitement, generally, despite having more realistic targets is another thing.

Read More

Continue Reading

Uncategorized

Part 1: Current State of the Housing Market; Overview for mid-March 2024

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024
A brief excerpt: This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to star…

Published

on

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024

A brief excerpt:
This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to start with inventory, since inventory usually tells the tale!
...
Here is a graph of new listing from Realtor.com’s February 2024 Monthly Housing Market Trends Report showing new listings were up 11.3% year-over-year in February. This is still well below pre-pandemic levels. From Realtor.com:

However, providing a boost to overall inventory, sellers turned out in higher numbers this February as newly listed homes were 11.3% above last year’s levels. This marked the fourth month of increasing listing activity after a 17-month streak of decline.
Note the seasonality for new listings. December and January are seasonally the weakest months of the year for new listings, followed by February and November. New listings will be up year-over-year in 2024, but we will have to wait for the March and April data to see how close new listings are to normal levels.

There are always people that need to sell due to the so-called 3 D’s: Death, Divorce, and Disease. Also, in certain times, some homeowners will need to sell due to unemployment or excessive debt (neither is much of an issue right now).

And there are homeowners who want to sell for a number of reasons: upsizing (more babies), downsizing, moving for a new job, or moving to a nicer home or location (move-up buyers). It is some of the “want to sell” group that has been locked in with the golden handcuffs over the last couple of years, since it is financially difficult to move when your current mortgage rate is around 3%, and your new mortgage rate will be in the 6 1/2% to 7% range.

But time is a factor for this “want to sell” group, and eventually some of them will take the plunge. That is probably why we are seeing more new listings now.
There is much more in the article.

Read More

Continue Reading

Government

RFK Jr. Reveals Vice President Contenders

RFK Jr. Reveals Vice President Contenders

Authored by Jeff Louderback via The Epoch Times,

New York Jets quarterback Aaron Rodgers and former…

Published

on

RFK Jr. Reveals Vice President Contenders

Authored by Jeff Louderback via The Epoch Times,

New York Jets quarterback Aaron Rodgers and former Minnesota governor and professional wrestler Jesse Ventura are among the potential running mates for independent presidential candidate Robert F. Kennedy Jr., the New York Times reported on March 12.

Citing “two people familiar with the discussions,” the New York Times wrote that Mr. Kennedy “recently approached” Mr. Rodgers and Mr. Ventura about the vice president’s role, “and both have welcomed the overtures.”

Mr. Kennedy has talked to Mr. Rodgers “pretty continuously” over the last month, according to the story. The candidate has kept in touch with Mr. Ventura since the former governor introduced him at a February voter rally in Tucson, Arizona.

Stefanie Spear, who is the campaign press secretary, told The Epoch Times on March 12 that “Mr. Kennedy did share with the New York Times that he’s considering Aaron Rodgers and Jesse Ventura as running mates along with others on a short list.”

Ms. Spear added that Mr. Kennedy will name his running mate in the upcoming weeks.

Former Democrat presidential candidates Andrew Yang and Tulsi Gabbard declined the opportunity to join Mr. Kennedy’s ticket, according to the New York Times.

Mr. Kennedy has also reportedly talked to Sen. Rand Paul (R-Ky.) about becoming his running mate.

Last week, Mr. Kennedy endorsed Mr. Paul to replace Sen. Mitch McConnell (R-Ky.) as the Senate Minority Leader after Mr. McConnell announced he would step down from the post at the end of the year.

CNN reported early on March 13 that Mr. Kennedy’s shortlist also includes motivational speaker Tony Robbins, Discovery Channel Host Mike Rowe, and civil rights attorney Tricia Lindsay. The Washington Post included the aforementioned names plus former Republican Massachusetts senator and U.S. Ambassador to New Zealand and Samoa, Scott Brown.

In April 2023, Mr. Kennedy entered the Democrat presidential primary to challenge President Joe Biden for the party’s 2024 nomination. Claiming that the Democrat National Committee was “rigging the primary” to stop candidates from opposing President Biden, Mr. Kennedy said last October that he would run as an independent.

This year, Mr. Kennedy’s campaign has shifted its focus to ballot access. He currently has qualified for the ballot as an independent in New Hampshire, Utah, and Nevada.

Mr. Kennedy also qualified for the ballot in Hawaii under the “We the People” party.

In January, Mr. Kennedy’s campaign said it had filed paperwork in six states to create a political party. The move was made to get his name on the ballots with fewer voter signatures than those states require for candidates not affiliated with a party.

The “We the People” party was established in five states: California, Delaware, Hawaii, Mississippi, and North Carolina. The “Texas Independent Party” was also formed.

A statement by Mr. Kennedy’s campaign reported that filing for political party status in the six states reduced the number of signatures required for him to gain ballot access by about 330,000.

Ballot access guidelines have created a sense of urgency to name a running mate. More than 20 states require independent and third-party candidates to have a vice presidential pick before collecting and submitting signatures.

Like Mr. Kennedy, Mr. Ventura is an outspoken critic of COVID-19 vaccine mandates and safety.

Mr. Ventura, 72, gained acclaim in the 1970s and 1980s as a professional wrestler known as Jesse “the Body” Ventura. He appeared in movies and television shows before entering the Minnesota gubernatorial race as a Reform Party headliner. He was a longshot candidate but prevailed and served one term.

Former pro wrestler Jesse Ventura in Washington on Oct. 4, 2013. (Brendan Smialowski/AFP via Getty Images)

In an interview on a YouTube podcast last December, Mr. Ventura was asked if he would accept an offer to run on Mr. Kennedy’s ticket.

“I would give it serious consideration. I won’t tell you yes or no. It will depend on my personal life. Would I want to commit myself at 72 for one year of hell (campaigning) and then four years (in office)?” Mr. Ventura said with a grin.

Mr. Rodgers, who spent his entire career as a quarterback for the Green Bay Packers before joining the New York Jets last season, remains under contract with the Jets. He has not publicly commented about joining Mr. Kennedy’s ticket, but the four-time NFL MVP endorsed him earlier this year and has stumped for him on podcasts.

The 40-year-old Rodgers is still under contract with the Jets after tearing his Achilles tendon in the 2023 season opener and being sidelined the rest of the year. The Jets are owned by Woody Johnson, a prominent donor to former President Donald Trump who served as U.S. Ambassador to Britain under President Trump.

Since the COVID-19 vaccine was introduced, Mr. Rodgers has been outspoken about health issues that can result from taking the shot. He told podcaster Joe Rogan that he has lost friends and sponsorship deals because of his decision not to get vaccinated.

Quarterback Aaron Rodgers of the New York Jets talks to reporters after training camp at Atlantic Health Jets Training Center in Florham Park, N.J., on July 26, 2023. (Rich Schultz/Getty Images)

Earlier this year, Mr. Rodgers challenged Kansas City Chiefs tight end Travis Kelce and Dr. Anthony Fauci to a debate.

Mr. Rodgers referred to Mr. Kelce, who signed an endorsement deal with vaccine manufacturer Pfizer, as “Mr. Pfizer.”

Dr. Fauci served as director of the National Institute of Allergy and Infectious Diseases from 1984 to 2022 and was chief medical adviser to the president from 2021 to 2022.

When Mr. Kennedy announces his running mate, it will mark another challenge met to help gain ballot access.

“In some states, the signature gathering window is not open. New York is one of those and is one of the most difficult with ballot access requirements,” Ms. Spear told The Epoch Times.

“We need our VP pick and our electors, and we have to gather 45,000 valid signatures. That means we will collect 72,000 since we have a 60 percent buffer in every state,” she added.

The window for gathering signatures in New York opens on April 16 and closes on May 28, Ms. Spear noted.

“Mississippi, North Carolina, and Oklahoma are the next three states we will most likely check off our list,” Ms. Spear added. “We are confident that Mr. Kennedy will be on the ballot in all 50 states and the District of Columbia. We have a strategist, petitioners, attorneys, and the overall momentum of the campaign.”

Tyler Durden Wed, 03/13/2024 - 15:45

Read More

Continue Reading

Uncategorized

Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45%…

Published

on

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45% of US respondents in 2023, according to the latest Harris Poll data. That’s exactly the same as the previous year.

Pharma’s highest point was in February 2021 — as Covid vaccines began to roll out — with a 62% positive US perception, and helping the industry land at an average 55% positive sentiment at the end of the year in Harris’ 2021 annual assessment of industries. The pharma industry’s reputation hit its most recent low at 32% in 2019, but it had hovered around 30% for more than a decade prior.

Rob Jekielek

“Pharma has sustained a lot of the gains, now basically one and half times higher than pre-Covid,” said Harris Poll managing director Rob Jekielek. “There is a question mark around how sustained it will be, but right now it feels like a new normal.”

The Harris survey spans 11 global markets and covers 13 industries. Pharma perception is even better abroad, with an average 58% of respondents notching favorable sentiments in 2023, just a slight slip from 60% in each of the two previous years.

Pharma’s solid global reputation puts it in the middle of the pack among international industries, ranking higher than government at 37% positive, insurance at 48%, financial services at 51% and health insurance at 52%. Pharma ranks just behind automotive (62%), manufacturing (63%) and consumer products (63%), although it lags behind leading industries like tech at 75% positive in the first spot, followed by grocery at 67%.

The bright spotlight on the pharma industry during Covid vaccine and drug development boosted its reputation, but Jekielek said there’s maybe an argument to be made that pharma is continuing to develop innovative drugs outside that spotlight.

“When you look at pharma reputation during Covid, you have clear sense of a very dynamic industry working very quickly and getting therapies and products to market. If you’re looking at things happening now, you could argue that pharma still probably doesn’t get enough credit for its advances, for example, in oncology treatments,” he said.

Read More

Continue Reading

Trending